Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models

Despite numerous therapeutic advances in the past decade, breast cancer is expected to cause over 42,000 deaths in the United States in 2019. Breast cancer had been considered an immunologically silent tumor; however recent findings suggest that immune cells play important roles in tumor growth even...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:NPJ Breast Cancer
Huvudupphovsmän: Leal, Ana S., Zydeck, Kayla, Carapellucci, Sarah, Reich, Lyndsey A., Zhang, Di, Moerland, Jessica A., Sporn, Michael B., Liby, Karen T.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group UK 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6825145/
https://ncbi.nlm.nih.gov/pubmed/31700995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-019-0135-5
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk